160 related articles for article (PubMed ID: 37243694)
1. Prediction of breast cancer risk for sisters of women attending screening.
Mao X; He W; Eriksson M; Lindström LS; Holowko N; Bajalica-Lagercrantz S; Hammarström M; Grassmann F; Humphreys K; Easton D; Hall P; Czene K
J Natl Cancer Inst; 2023 Nov; 115(11):1310-1317. PubMed ID: 37243694
[TBL] [Abstract][Full Text] [Related]
2. Inherited factors contribute to an inverse association between preeclampsia and breast cancer.
Yang H; He W; Eriksson M; Li J; Holowko N; Chiesa F; Hall P; Czene K
Breast Cancer Res; 2018 Jan; 20(1):6. PubMed ID: 29361985
[TBL] [Abstract][Full Text] [Related]
3. Factors Associated With False-Positive Recalls in Mammography Screening.
Mao X; He W; Humphreys K; Eriksson M; Holowko N; Strand F; Hall P; Czene K
J Natl Compr Canc Netw; 2023 Feb; 21(2):143-152.e4. PubMed ID: 36791753
[TBL] [Abstract][Full Text] [Related]
4. Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density.
Brentnall AR; Cuzick J; Buist DSM; Bowles EJA
JAMA Oncol; 2018 Sep; 4(9):e180174. PubMed ID: 29621362
[TBL] [Abstract][Full Text] [Related]
5. Heritability of Mammographic Breast Density, Density Change, Microcalcifications, and Masses.
Holowko N; Eriksson M; Kuja-Halkola R; Azam S; He W; Hall P; Czene K
Cancer Res; 2020 Apr; 80(7):1590-1600. PubMed ID: 32241951
[TBL] [Abstract][Full Text] [Related]
6. Identification of Women at High Risk of Breast Cancer Who Need Supplemental Screening.
Eriksson M; Czene K; Strand F; Zackrisson S; Lindholm P; Lång K; Förnvik D; Sartor H; Mavaddat N; Easton D; Hall P
Radiology; 2020 Nov; 297(2):327-333. PubMed ID: 32897160
[TBL] [Abstract][Full Text] [Related]
7. Mammographic features are associated with cardiometabolic disease risk and mortality.
Grassmann F; Yang H; Eriksson M; Azam S; Hall P; Czene K
Eur Heart J; 2021 Sep; 42(34):3361-3370. PubMed ID: 34338750
[TBL] [Abstract][Full Text] [Related]
8. Inclusion of Endogenous Plasma Dehydroepiandrosterone Sulfate and Mammographic Density in Risk Prediction Models for Breast Cancer.
Gabrielson M; Ubhayasekera KA; Acharya SR; Franko MA; Eriksson M; Bergquist J; Czene K; Hall P
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):574-581. PubMed ID: 31948996
[TBL] [Abstract][Full Text] [Related]
9. A case-control evaluation of 143 single nucleotide polymorphisms for breast cancer risk stratification with classical factors and mammographic density.
Brentnall AR; van Veen EM; Harkness EF; Rafiq S; Byers H; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
Int J Cancer; 2020 Apr; 146(8):2122-2129. PubMed ID: 31251818
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer pathology and stage are better predicted by risk stratification models that include mammographic density and common genetic variants.
Evans DGR; Harkness EF; Brentnall AR; van Veen EM; Astley SM; Byers H; Sampson S; Southworth J; Stavrinos P; Howell SJ; Maxwell AJ; Howell A; Newman WG; Cuzick J
Breast Cancer Res Treat; 2019 Jul; 176(1):141-148. PubMed ID: 30941651
[TBL] [Abstract][Full Text] [Related]
11. Comparative validation of the BOADICEA and Tyrer-Cuzick breast cancer risk models incorporating classical risk factors and polygenic risk in a population-based prospective cohort of women of European ancestry.
Pal Choudhury P; Brook MN; Hurson AN; Lee A; Mulder CV; Coulson P; Schoemaker MJ; Jones ME; Swerdlow AJ; Chatterjee N; Antoniou AC; Garcia-Closas M
Breast Cancer Res; 2021 Feb; 23(1):22. PubMed ID: 33588869
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Performance of an Image-Based Short-Term Risk Model for Breast Cancer.
Eriksson M; Czene K; Vachon C; Conant EF; Hall P
J Clin Oncol; 2023 May; 41(14):2536-2545. PubMed ID: 36930854
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of the BOADICEA multifactorial breast cancer risk prediction model in a large prospective cohort study.
Yang X; Eriksson M; Czene K; Lee A; Leslie G; Lush M; Wang J; Dennis J; Dorling L; Carvalho S; Mavaddat N; Simard J; Schmidt MK; Easton DF; Hall P; Antoniou AC
J Med Genet; 2022 Dec; 59(12):1196-1205. PubMed ID: 36162852
[TBL] [Abstract][Full Text] [Related]
14. A clinical model for identifying the short-term risk of breast cancer.
Eriksson M; Czene K; Pawitan Y; Leifland K; Darabi H; Hall P
Breast Cancer Res; 2017 Mar; 19(1):29. PubMed ID: 28288659
[TBL] [Abstract][Full Text] [Related]
15. Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction.
van Veen EM; Brentnall AR; Byers H; Harkness EF; Astley SM; Sampson S; Howell A; Newman WG; Cuzick J; Evans DGR
JAMA Oncol; 2018 Apr; 4(4):476-482. PubMed ID: 29346471
[TBL] [Abstract][Full Text] [Related]
16. Mammographic features of benign breast lesions and risk of subsequent breast cancer in women attending breast cancer screening.
Posso M; Alcántara R; Vázquez I; Comerma L; Baré M; Louro J; Quintana MJ; Román M; Marcos-Gragera R; Vernet-Tomas M; Saladie F; Vidal C; Bargalló X; Peñalva L; Sala M; Castells X;
Eur Radiol; 2022 Jan; 32(1):621-629. PubMed ID: 34156554
[TBL] [Abstract][Full Text] [Related]
17. The combined effect of mammographic texture and density on breast cancer risk: a cohort study.
Wanders JOP; van Gils CH; Karssemeijer N; Holland K; Kallenberg M; Peeters PHM; Nielsen M; Lillholm M
Breast Cancer Res; 2018 May; 20(1):36. PubMed ID: 29720220
[TBL] [Abstract][Full Text] [Related]
18. Effects of statin use on volumetric mammographic density: results from the KARMA study.
Skarping I; Brand JS; Hall P; Borgquist S
BMC Cancer; 2015 May; 15():435. PubMed ID: 26016855
[TBL] [Abstract][Full Text] [Related]
19. Automated measurement of volumetric mammographic density: a tool for widespread breast cancer risk assessment.
Brand JS; Czene K; Shepherd JA; Leifland K; Heddson B; Sundbom A; Eriksson M; Li J; Humphreys K; Hall P
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1764-72. PubMed ID: 25012995
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer risk prediction using Tyrer-Cuzick algorithm with an 18-SNPs polygenic risk score in a European population with below-average breast cancer incidence.
Oblak T; Škerl P; Narang BJ; Blagus R; Krajc M; Novaković S; Žgajnar J
Breast; 2023 Dec; 72():103590. PubMed ID: 37857130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
